News headlines about Roka Bioscience (NASDAQ:ROKA) have trended somewhat positive this week, according to Accern Sentiment Analysis. Accern identifies negative and positive news coverage by reviewing more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Roka Bioscience earned a media sentiment score of 0.02 on Accern’s scale. Accern also assigned media headlines about the medical research company an impact score of 45.0757989085946 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.

Shares of Roka Bioscience (ROKA) traded up 3.13% during midday trading on Wednesday, hitting $0.99. The company’s stock had a trading volume of 39,801 shares. Roka Bioscience has a 52-week low of $0.85 and a 52-week high of $9.30. The stock’s 50 day moving average is $1.62 and its 200-day moving average is $2.79. The firm’s market cap is $4.96 million.

COPYRIGHT VIOLATION WARNING: This piece was originally posted by Watch List News and is the property of of Watch List News. If you are viewing this piece on another domain, it was illegally copied and republished in violation of United States & international trademark & copyright legislation. The correct version of this piece can be accessed at

In other news, major shareholder Orbimed Advisors Llc sold 75,276 shares of the business’s stock in a transaction on Tuesday, August 22nd. The shares were sold at an average price of $1.52, for a total transaction of $114,419.52. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Insiders have sold a total of 90,676 shares of company stock valued at $137,520 over the last 90 days. Company insiders own 29.10% of the company’s stock.

About Roka Bioscience

Roka Bioscience, Inc is a molecular diagnostics company. The Company is focused on the development and commercialization of molecular assay technologies for the detection of foodborne pathogens under the Atlas brand name. The Company offers Atlas Detection Assays and Atlas instrument in the North American food safety testing market and has rights to develop and commercialize its molecular testing solutions for a range of other industrial applications.

Insider Buying and Selling by Quarter for Roka Bioscience (NASDAQ:ROKA)

Receive News & Ratings for Roka Bioscience Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roka Bioscience Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.